email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
556 - 570
of 3615 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Kelun-Biotech Signs $9.5 Billion Deal with Merck for Seven ADC Candidates
$5.00
Available
XtalPi Collaborates with Singapore’s EDDC to Discover NSCLC Candidates
$5.00
Available
Shanghai Group Leads $20 Million Round for Israel’s Biomica, a Microbiome Company
$5.00
Available
Staidson Bio In-Licenses mAb Complement Therapy for COVID in $10 Million Deal
$5.00
Available
LianBio Sells Rights for RSV Therapy to Pfizer in $155 Million Deal
$5.00
Available
Kira Pharma Starts China-Australia Trials of Dual Complement Pathway Candidate
$5.00
Available
Innovent Enters $95 Million Agreement to In-License Gout Treatment
$5.00
Available
Alternative Bio Lands $15 Million to Develop Oncology Drugs based on Novel Enzymes
$5.00
Available
Suzhou 4B Technologies Closes $14 Million Pre-B Financing for Neuro Drugs
$5.00
Available
BeiGene Says its BTK Inhibitor Out-Performs Janssen’s Imbruvica
$5.00
Available
Boston Scientific Pays $523 Million for Control of Acotec, a Beijing Device Company
$5.00
Available
Nanjing Biosion Forms ADC Discovery Collaboration with Boston’s ImmunoGen
$5.00
Available
HitGen Forms Partnership with Nitrase to Develop Novel Enzyme Inhibitors
$5.00
Available
CARsgen Files NDA for China Approval of CAR-T Based on Phase II Data
$5.00
Available
GenScript to Build Synthetic Biology Library with Singapore’s Allozymes
$5.00
Available